Hadebe S
Methods Mol Biol. 2025; 2909:3-17.
PMID: 40029511
DOI: 10.1007/978-1-0716-4442-3_1.
Han L, Wu T, Zhang Q, Qi A, Zhou X
J Immunol Res. 2025; 2025:5006201.
PMID: 39950084
PMC: 11824399.
DOI: 10.1155/jimr/5006201.
Gutzeit C, Grasset E, Matthews D, Maglione P, Britton G, Miller H
Sci Adv. 2025; 11(7):eado9455.
PMID: 39937896
PMC: 11817949.
DOI: 10.1126/sciadv.ado9455.
Galipeau Y, Cooper C, Langlois M
Front Immunol. 2025; 15():1509289.
PMID: 39835117
PMC: 11743527.
DOI: 10.3389/fimmu.2024.1509289.
Hu T, Liu C, Lei M, Zeng Q, Li L, Tang H
Signal Transduct Target Ther. 2024; 9(1):268.
PMID: 39379377
PMC: 11461632.
DOI: 10.1038/s41392-024-01954-6.
Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations.
Lei W, Lo Y, Tsumura M, Ding J, Lo C, Lin Y
J Clin Immunol. 2024; 44(8):184.
PMID: 39177867
DOI: 10.1007/s10875-024-01776-9.
Development of a Mature B Lymphocyte Probe through Gating-Oriented Live-Cell Distinction (GOLD) and Selective Imaging of Topical Spleen.
Cho H, Kwon H, Kim Y, Kim K, Lee E, Kang N
JACS Au. 2024; 4(4):1450-1457.
PMID: 38665660
PMC: 11040558.
DOI: 10.1021/jacsau.4c00001.
Targeted therapy for multiple myeloma: an overview on CD138-based strategies.
Riccardi F, Tangredi C, Dal Bo M, Toffoli G
Front Oncol. 2024; 14:1370854.
PMID: 38655136
PMC: 11035824.
DOI: 10.3389/fonc.2024.1370854.
B cells and atherosclerosis: A HIV perspective.
Obare L, Bonami R, Doran A, Wanjalla C
J Cell Physiol. 2024; 239(6):e31270.
PMID: 38651687
PMC: 11209796.
DOI: 10.1002/jcp.31270.
Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host.
Florova M, Abreu-Mota T, Paesen G, Beetschen A, Cornille K, Marx A
Proc Natl Acad Sci U S A. 2024; 121(11):e2318657121.
PMID: 38446855
PMC: 10945855.
DOI: 10.1073/pnas.2318657121.
Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help.
Fiske B, Getahun A
J Immunol. 2024; 212(7):1150-1160.
PMID: 38353615
PMC: 10948302.
DOI: 10.4049/jimmunol.2300108.
mIgM-mediated splenic marginal zone B cells targeting of folic acid for immunological evasion.
Wang H, Jiang Z, Guo Z, Luo G, Ding T, Zhan C
Acta Pharm Sin B. 2024; 14(2):808-820.
PMID: 38322341
PMC: 10840397.
DOI: 10.1016/j.apsb.2023.09.011.
Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus.
Araki Y, Mimura T
Int J Mol Sci. 2024; 25(2).
PMID: 38256093
PMC: 10816225.
DOI: 10.3390/ijms25021019.
Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
Ono C, Tanaka S, Myouzen K, Iwasaki T, Ueda M, Oda Y
Front Immunol. 2023; 14:1276014.
PMID: 37841260
PMC: 10569490.
DOI: 10.3389/fimmu.2023.1276014.
Advances in the Study of Immunosuppressive Mechanisms in Sepsis.
Fu X, Liu Z, Wang Y
J Inflamm Res. 2023; 16:3967-3981.
PMID: 37706064
PMC: 10497210.
DOI: 10.2147/JIR.S426007.
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenografts.
Hughes K, Evans K, Earley E, Smith C, Erickson S, Stearns T
Pediatr Blood Cancer. 2023; :e30503.
PMID: 37339930
PMC: 10730772.
DOI: 10.1002/pbc.30503.
Identification of an anergic BND cell-derived activated B cell population (BND2) in young-onset type 1 diabetes patients.
Stensland Z, Magera C, Broncucia H, Gomez B, Rios-Guzman N, Wells K
J Exp Med. 2023; 220(8).
PMID: 37184563
PMC: 10192302.
DOI: 10.1084/jem.20221604.
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells.
Zheng Y, Yu M, Chen Y, Xue L, Zhu W, Fu G
J Immunol. 2023; 210(9):1222-1235.
PMID: 36961449
PMC: 10156913.
DOI: 10.4049/jimmunol.2200639.
Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile.
Henning A, Budeebazar M, Boldbaatar D, Yagaanbuyant D, Duger D, Batsukh K
iScience. 2023; 26(1):105801.
PMID: 36619973
PMC: 9813790.
DOI: 10.1016/j.isci.2022.105801.
Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies.
Li X, Liao D, Li Z, Li J, Diaz M, Verkoczy L
Front Immunol. 2022; 13:977630.
PMID: 36479128
PMC: 9720396.
DOI: 10.3389/fimmu.2022.977630.